Clindamycin therapy of staphylococcus aureus endocarditis
The DOI matches its Crossref record; 13 of the 14 references it cites were found in a registry or an index.
Abstract
A 42 year old heroin addict with Staphylococcus aureus endocarditis of the mitral valve was treated with clindamycin phosphate, 600 mg intramuscularly, every 6 hours. The initial clinical response was excellent and blood cultures became negative. On the 26th day of clindamycin therapy, fever developed and six blood cultures taken during a 72 hour period grew Staph. aureus. The patient was subsequently cured with a six week course of nafcillin plus gentamicin followed by cloxacillin. The Staph. aureus isolated before clindamycin therapy and during relapse phage-typed 29/52/52A/79/80 and was resistant to penicillin G. The susceptibility of both Staph. aureus isolates to 19 antibiotics was unchanged. However, the Stahph. aureus developed marked resistance to clindamycin, lincomycin and erythromycin, to which the original isolate was susceptible. The resistance to clindamycin and lincomycin was heterogeneous whereas the entire cell population became homogeneously highly resistant to erythromycin. These antibiotics were not inactivated in vitro by the rapidly growing resistant Staph. aureus. The most likely site of resistance was at the 50 S subunit of the bacterial ribosome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Simplified, Accurate Method for Antibiotic Assay of Clinical Specimens
Bennett, J. V., Brodie, J. L., Benner, E. J., & Kirby, W. (1966) · Applied Microbiology · doi:10.1128/aem.14.2.170-177.1966 · Cited by 955
Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus
Sande, M. A., & Johnson, M. L. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/131.4.367 · Cited by 158
Some salient features of staphylococcus aureus endocarditis
Watanakunakorn, C., Tan, J. S., & Phair, J. (1973) · The American Journal of Medicine · doi:10.1016/0002-9343(73)90043-0 · Cited by 127
Self-citationChanging epidemiology and newer aspects of infective endocarditis.
WATANAKUNAKORN, C. (1977) · PubMed · Cited by 102
Self-citationPharmacokinetic Studies of Clindamycin Phosphate
DeHaan, R. M., Metzler, C. M., Schellenberg, D. B., & Vandenbosch, W. D. (1973) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1973.tb00208.x · Cited by 96
Enhancement of the Effects of Anti-Staphylococcal Antibiotics by Aminoglycosides
Watanakunakorn, C., & Glotzbecker, C. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.6.802 · Cited by 92
Self-citationANTIBIOTIC SENSITIVITY TESTING
Beaney, N., Goodwin, N. G., Jones, R. V., Winter, R., & Sippe, G. R. (1970) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1970.tb78003.x · Cited by 66
Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin.
McGehee, R. F., Ff, B., & Finland, M. (1968) · PubMed · Cited by 49
Clindamycin-associated hepatotoxicity
Elmore, M. F., RISSING, J. P., Rink, L. D., & Brooks, G. F. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90015-1 · Cited by 32
Hash, J. H. (1972) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.12.040172.000343 · Cited by 29
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Pankey, G. A., & Sabath, L. D. (2004) · Clinical Infectious Diseases · doi:10.1086/381972 · Cited by 1,201
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 628
Metadata
- Authors
- Watanakunakorn, C.
- Corresponding author
- Watanakunakorn, Chatrchai
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 1976-03
- Volume
- 60
- Issue
- 3
- Pages
- 419-425
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W1568339559
- Semantic Scholar
- 28180420979db59bac67f7388e4e9632586c1ea3
- Cited by
- 106
- References
- 14
- Citations by year
- 2025: 2 · 2024: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 3 · 2013: 3 · 2012: 2
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The American Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- Staphylococcus aureus endocarditis, clindamycin resistance, mitral valve endocarditis, heroin addiction, penicillinase production, penicillin resistance, lincomycin resistance, erythromycin resistance, 50S ribosomal subunit, nafcillin, gentamicin, cloxacillin, phage typing
- MeSH terms
- Adult, Clindamycin, Cloxacillin, Erythromycin, Gentamicins, Heroin Dependence, Humans, Lincomycin, Male, Nafcillin, Penicillin Resistance, Recurrence, Staphylococcal Infections, Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clindamycin therapy of staphylococcus aureus endocarditis. https://app.cochat.ai/papers/10.1016/0002-9343(76)90758-0
- The paper
- Watanakunakorn, C. (1976). Clindamycin therapy of staphylococcus aureus endocarditis. The American Journal of Medicine. https://doi.org/10.1016/0002-9343(76)90758-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.